Results from the phase 3 monarchE trial on the addition of abemaciclib to endocrine therapy in patients with early breast cancer were presented at the 17th St. Gillen International Breast Cancer Conference.
A team of investigators sought to determine the significance of the immunologic aspects of the antitumor response and reported their findings at the 17th St. Gillen International Breast Cancer Conference 2021.
A team of investigators who conducted a meta-analysis to evaluate the safety and efficacy of tyrosine kinase inhibitors in patients with HER-2 positive breast cancer with brain metastases presented their findings at the 17th St. Gallen International Breast Cancer Conference.
Investigators surveyed patients in the international INSPIRE registry to assess the impact of adjuvant endocrine therapy on health-related quality of life in women undergoing nipple-sparing mastectomy for breast cancer.
The LAVENDER study evaluated the safety and tolerability of ABP 980, a biosimilar approved for patients with metastatic breast cancer, early breast cancer, adjuvant breast cancer, and metastatic gastric cancer.